Development of MKK4 inhibitors for liver regeneration

Jordan Hindson
DOI: https://doi.org/10.1038/s41575-024-00940-1
2024-05-16
Nature Reviews Gastroenterology & Hepatology
Abstract:The kinase MKK4 is a regulator of hepatocyte regeneration. A new study published in Cell reports the development of small-molecule inhibitors of MKK4. HRX215 increased liver regeneration post-hepatectomy in mouse and pig models and increased hepatocyte proliferation in fibrotic mouse livers post-partial hepatectomy. In addition, HRX215 treatment prevented post-hepatectomy liver failure in a lethal 85% hepatectomy model in pigs and enabled their survival. Next, a phase I trial (EudraCT 2021-000193-28; n = 48 healthy volunteers) of HRX215 demonstrated positive safety and pharmacokinetics.
gastroenterology & hepatology
What problem does this paper attempt to address?